Mitotic specific phosphorylation of serine-1212 in human DNA topoisomerase IIalpha.
It is known that topoisomerase IIalpha is phosphorylated by several kinases. To elucidate the role of phosphorylation of topoisomerase IIalpha in the cell cycle, we have examined the cell cycle behavior of phosphorylated topoisomerase IIalpha in HeLa cells using antibodies against several phospho-oligopeptides of this enzyme. Here we demonstrate that serine1212 in topoisomerase IIalpha is phosphorylated only in the mitotic phase. Using an antibody against an oligopeptide containing phosphoserine-1212 in topoisomerase IIalpha (PS1212), subcellular localization of topoisomerase IIalpha phosphorylated at serine1212 was examined by indirect immunofluorescence staining, and compared with that of overall topoisomerase IIalpha. Serine1212-phosphorylated topoisomerase IIalpha was localized specifically on mitotic chromosomes, but not on interphase chromosomes; this result contrasts with overall topoisomerase IIalpha which was observed on chomosomes in both interphase and mitosis. Serine1212-phosphorylated topoisomerase lIalpha first appeared on chromosome arms in prophase, became concentrated on the centromeres in metaphase, and disappeared in early telophase. In addition, ICRF-193, a catalytic inhibitor of topoisomerase II, prevented accumulation of serine1212-phosphorylated topoisomerase IIalpha at the centromeres. These results indicate that serine1212 of topoisomerase IIalpha is phosphorylated specifically during mitosis, and suggest that the serine1212-phosphorylated topoisomerase IIalpha acts on resolving topological constraint progressively from the chromosome arm to the centromere during metaphase chromosome condensation.
Ishida
R
R
Laboratory of Chemotherapy, Aichi Cancer Center Research Institute, Nagoya, Japan.
Takashima
R
R
Koujin
T
T
Shibata
M
M
Nozaki
N
N
Seto
M
M
Mori
H
H
Haraguchi
T
T
Hiraoka
Y
Y
D000911:Antibodies, Monoclonal / Q000276:immunology; D000951:Antigens, Neoplasm; D002453:Cell Cycle; D002503:Centromere / Q000201:enzymology; D002875:Chromosomes / Q000201:enzymology; D004250:DNA Topoisomerases, Type II / Q000737:chemistry* / Q000276:immunology / Q000378:metabolism*; D004268:DNA-Binding Proteins; D054659:Diketopiperazines; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005434:Flow Cytometry; D019084:Fluorescent Antibody Technique, Indirect; D006367:HeLa Cells; D006801:Humans; D008856:Microscopy, Fluorescence; D008938:Mitosis; D010766:Phosphorylation; D010879:Piperazines / Q000494:pharmacology; D012694:Serine / Q000378:metabolism*; D059005:Topoisomerase II Inhibitors
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D004268:DNA-Binding Proteins; D054659:Diketopiperazines; D004791:Enzyme Inhibitors; D010879:Piperazines; D059005:Topoisomerase II Inhibitors; C070899:4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione; D012694:Serine; D004250:DNA Topoisomerases, Type II